Patents by Inventor Chin Hee Mun

Chin Hee Mun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising punicalagin for inhibiting PAR2 activity
    Patent number: 11957699
    Abstract: The present invention relates to a composition for inhibiting PAR2 activity including punicalagin, and more specifically, the present invention provides a composition for inhibiting PAR2 activity including punicalagin, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition, health functional food composition, or cosmetic composition for preventing or treating an inflammatory disease or pruritis.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: April 16, 2024
    Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Wan Namkung, Sang Won Lee, Yo Han Seo, Chin Hee Mun
  • Pharmaceutical composition for treating inflammatory diseases comprising germanium telluride nanosheets coated with polyvinylpyrrolidone
    Patent number: 11896609
    Abstract: The present invention relates to a composition for treating inflammatory diseases comprising germanium telluride nanosheets coated with polyvinylpyrrolidone, and the nanosheets have excellent anti-inflammatory and thus are excellent in treating inflammatory bowel disease and psoriasis.
    Type: Grant
    Filed: August 23, 2022
    Date of Patent: February 13, 2024
    Assignee: Industry-Academic Cooperation Foundation
    Inventors: Kyung-Hwa Yoo, Jun Ho Song, Yong-Beom Park, Sun-Mi Lee, Chin Hee Mun, Taejun Yoon
  • PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES COMPRISING GERMANIUM TELLURIDE NANOSHEETS COATED WITH POLYVINYLPYRROLIDONE
    Publication number: 20230080524
    Abstract: The present invention relates to a composition for treating inflammatory diseases comprising germanium telluride nanosheets coated with polyvinylpyrrolidone, and the nanosheets have excellent anti-inflammatory and thus are excellent in treating inflammatory bowel disease and psoriasis.
    Type: Application
    Filed: August 23, 2022
    Publication date: March 16, 2023
    Inventors: Kyung-Hwa Yoo, Jun Ho Song, Yong-Beom Park, Sun-Mi Lee, Chin Hee Mun, Taejun Yoon
  • COMPOSITION COMPRISING PUNICALAGIN FOR INHIBITING PAR2 ACTIVITY
    Publication number: 20210308165
    Abstract: The present invention relates to a composition for inhibiting PAR2 activity including punicalagin, and more specifically, the present invention provides a composition for inhibiting PAR2 activity including punicalagin, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition, health functional food composition, or cosmetic composition for preventing or treating an inflammatory disease or pruritis.
    Type: Application
    Filed: July 30, 2019
    Publication date: October 7, 2021
    Applicant: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Wan NAMKUNG, Sang Won LEE, Yo Han SEO, Chin Hee MUN
  • Pharmacological Composition for Prevention or Treatment of Lupus, Comprising Mesenchymal Stem Cell-Derived Secretome
    Publication number: 20200353007
    Abstract: The present disclosure relates to a composition for various applications, which is capable of effectively preventing, ameliorating or treating lupus using a secretome derived from mesenchymal stem cells. The secretome derived from mesenchymal stem cells according to the present disclosure may significantly decrease mortality and the amount of proteinuria, and may increase body weight, decrease the expression of serum creatinine, and inhibit glomerular, coronary and vascular damage in kidney tissue. Furthermore, the secretome may reduce the size of an enlarged spleen and reduce the number of splenocytes and CD4-positive T cells. In addition, the secretome may increase the expression of the anti-inflammatory cytokines IL-10 and TGF-?1 in serum, and decrease the expression of anti-dsDNA antibody.
    Type: Application
    Filed: August 27, 2018
    Publication date: November 12, 2020
    Inventors: Yong Beom Park, Chin Hee Mun
  • Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same
    Publication number: 20190338001
    Abstract: The present invention relates to a composition and a fusion protein for prevention or treatment of autoimmune diseases, which contain a Smad protein, and provides a method for prevention or treatment of autoimmune diseases, including lupus nephritis and rheumatoid arthritis.
    Type: Application
    Filed: June 17, 2019
    Publication date: November 7, 2019
    Inventors: Sang-Kyou Lee, Sung-Dong Park, Sang Won Lee, Chin Hee Mun
  • A Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same
    Publication number: 20190315820
    Abstract: The present invention relates to a composition and a fusion protein for prevention or treatment of autoimmune diseases, which contain a Smad protein, and provides a method for prevention or treatment of autoimmune diseases, including lupus nephritis and rheumatoid arthritis.
    Type: Application
    Filed: June 17, 2019
    Publication date: October 17, 2019
    Inventors: Sang-Kyou Lee, Sung-Dong Park, Sang Won Lee, Chin Hee Mun